Приказ основних података о документу

dc.creatorĐunić, Irena
dc.creatorDopsaj, Violeta
dc.creatorMiljić, Predrag
dc.creatorNovković, Aleksandra
dc.creatorSuvajdžić-Vuković, Nada
dc.creatorTomin, Dragica
dc.creatorElezović, I
dc.date.accessioned2019-09-02T11:48:38Z
dc.date.available2019-09-02T11:48:38Z
dc.date.issued2015
dc.identifier.issn1538-7933
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2463
dc.description.abstractBackground: Due to recurrent bleding in haemophilia patients, the effect of blood, i.e. free iron in the joint spaces, could initiate releasing markers of oxidative stress in physiological fluids. Aims: The aim of this study were to estimate the influence of differ- ent prophylaxis regimens for severe haemophilia on alternations of oxidative stress markers in serum: a) advanced oxidation protein products (AOPP), b) paraoxonase-1 (PON1) and c) sulfhydril groups (SHG). Methods: The study included 20 adult patients with severe haemo- philia. Five patients with haemophilia A received prophylaxis with FVIII concentrate in the standard dose of 20 IU kg 1 three times per week, while another five patients with haemophilia A were given an intermediate dose of FVIII - 10–15 IU kg 1 thrice weekly. Seven patients with haemophilia A and three with haemophilia B, received FVIII/IX concentrate only on-demand. The following oxidative stress markers were measured: a) AOPP, b) PON1 and c) SHG. Serum sam- ples were collected initially, before the start of treatment (labelled AOPP-1, PON1-1 and SHG-1) and after 3 months follow-up (labelled AOPP-2, PON1-2 and SHG-2). Results: The mean age of the patients was 32 years (range 19–55). In the group of patients given standard dose prophylaxis, the mean values of AOPP-2 (P = 0.018), PON1-2 (P = 0.043) and SHG-2 (P = 0.045) were significantly lower than those for AOPP-1, PON1- 1 and SHG-1. Likewise, the mean values for AOPP-2 (P = 0.047) and PON1-2 (P = 0.039) in the five patients receiving intermediate dose prophylaxis were also decreased when compared to initial val- ues, but SHG level was not significantly changed. In patients trea- ted on demand the mean values for AOPP, PON1 and SHG did not alter significantly. Conclusion: The results of this investigation showed that treatment of patients with severe haemophilia by continuous prophylaxis with intravenously applied FVIII/IX provides less oxidative stress reflected as decreasing of markers such as AOPP, PON1 and SHG.
dc.publisherElsevier Inc
dc.rightsopenAccess
dc.sourceJournal of Thrombosis and Haemostasis
dc.titleAlternations of oxidative stress markers in patients with severe haemophilia treated by different prophylaxis regimensen
dc.typeconferenceObject
dc.rights.licenseARR
dcterms.abstractДопсај, Виолета; Ђунић, Ирена; Елезовић, И; Томин, Драгица; Сувајджић-Вуковић, Нада; Миљић, Предраг; Новковић, Aлександра;
dc.citation.volume13
dc.citation.issueSupplement 2
dc.citation.spage353
dc.citation.epage353
dc.citation.other13: 353-353
dc.citation.rankaM21
dc.description.otherXXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015
dc.identifier.wos000356426902409
dc.identifier.doi10.1111/jth.12993
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу